QT
AXDX

Quantamental Technologies’s Accelerate Diagnostics AXDX Stock Holding History

Quantamental Technologies’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-140
Closed -$16K – 1472
2018
Q4 		$16K Buy
+140
New +$20.7K 0.01% 1059

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Quantamental Technologies's AXDX Position: Q1 2019 in Review

Quantamental Technologies sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 140 shares — an estimated $16K sold.

Quantamental Technologies first reported a position in AXDX in Q4 2018 and held it in 1 quarter. The position peaked at $16K in Q4 2018. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

  • Quantamental Technologies reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Quantamental Technologies sold 140 Accelerate Diagnostics shares in Q1 2019, an estimated $16K.
  • Quantamental Technologies first reported a position in Accelerate Diagnostics in Q4 2018 and held it in 1 quarter.
  • Quantamental Technologies's Accelerate Diagnostics position peaked at $16K in Q4 2018.
  • 114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Quantamental Technologies's 13F filing for Q1 2019, filed 29 Apr 2019.